Eric Lefebvre's Net Worth

$7.67 Million

Estimate Recalculated Sep 9, 2024 12:24AM EST

Who is Eric Lefebvre

Eric Lefebvre has an estimated net worth of $7.67 Million. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., PLIANT THERAPEUTICS, INC., and Regado Biosciences Inc.

SEC CIK

Eric Lefebvre's CIK is 0001614741

Past Insider Trading and Trends

2023 was Eric Lefebvre's most active year for acquiring shares with 5 total transactions. Eric Lefebvre's most active month to acquire stocks was the month of December. 2021 was Eric Lefebvre's most active year for disposing of shares, totalling 5 transactions. Eric Lefebvre's most active month to dispose stocks was the month of February. 2022 saw Eric Lefebvre paying a total of $0.00 for 276,876 shares, this is the most they've acquired in one year. In 2023 Eric Lefebvre cashed out on 101,066 shares for a total of $3,027,838.14, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CymaBay Therapeutics, Inc.

Investor
Updated Mar 22, 2024
Form 4
-100.00%
-154.01K
Mar 22, 2024
Disposition
Mar 22
Form 4
14.01K
Jan 26, 2024
14.01K
Grant
Jan 24
Form 4
25.00K
Jan 27, 2023
25.00K
Grant
Jan 25
Form 4
115.00K
Mar 21, 2022
115.00K
Grant
Mar 21
Form 3
Mar 21, 2022
Showing 5 results

PLIANT THERAPEUTICS, INC.

Chief Medical Officer
Updated Jul 12, 2024
Form 4
-5.47%
-12.32K
$11.56
-$142.41K
Jul 12, 2024
213.05K
Sale
ScheduledJul 10
Form 4
11.95%
24.06K
Jul 11, 2024
225.37K
Grant
Jul 09
Form 4
82.02%
128.70K
Jan 24, 2024
285.62K
Grant
Jan 23
Form 4
-6.16%
-10.29K
$17.23
-$177.38K
Jan 19, 2024
156.92K
Sale
ScheduledJan 17
Form 4
-11.78%
-22.32K
$18.01
-$401.98K
Jul 19, 2023
167.22K
Sale
Jul 17
Form 4
30.01%
43.75K
Jul 18, 2023
189.54K
Grant
Jul 14
Form 4
-7.16%
-11.24K
$26.52
-$298.23K
Apr 03, 2023
145.79K
Sale
Mar 30
Form 4
16.18%
21.87K
Mar 31, 2023
157.03K
Grant
Mar 29
Form 4
178.09%
137.00K
Jan 27, 2023
213.93K
Grant
Jan 25
Form 4
-46.74%
-67.50K
$34.48
-$2.33M
Jan 25, 2023
76.93K
Sale
ScheduledJan 23
Form 4
8.24%
10.99K
$19.10
-$207.97K
Dec 21, 2022
144.43K
Grant
Dec 19 - Dec 20
Form 4
-3.61%
-5.00K
$25.05
-$125.24K
Oct 27, 2022
133.44K
Sale
ScheduledOct 25
Form 4
-2.12%
-3.00K
$20.00
-$60.00K
Jul 13, 2022
138.44K
Sale
ScheduledJul 11
Form 4
140.00K
Feb 02, 2022
140.00K
Grant
Jan 26
Form 4
-8.36%
-12.50K
$28.87
-$360.82K
Jun 22, 2021
137.08K
Sale
ScheduledJun 18
Form 4
-7.71%
-12.50K
$39.41
-$492.68K
Mar 19, 2021
149.58K
Sale
ScheduledMar 18
Form 4
73.25K
Jan 26, 2021
73.25K
Grant
Jan 23
Form 4
-7.16%
-12.50K
$26.54
-$331.75K
Dec 21, 2020
162.08K
Sale
ScheduledDec 18
Form 3
Jun 02, 2020
174.58K
Showing 19 results

Regado Biosciences Inc

Chief Medical Officer
Updated May 06, 2015
Form 3
May 06, 2015
Showing 1 results